Warning: mysqli_query(): MySQL server has gone away in /data/49/5/74/117/5074280/user/6104038/htdocs/mtsrestore/wp-includes/wp-db.php on line 2162

Warning: mysqli_query(): Error reading result set's header in /data/49/5/74/117/5074280/user/6104038/htdocs/mtsrestore/wp-includes/wp-db.php on line 2162
Inflammation – 3Sixty Pharma Solutions LLC

GI-targeted oral JAK inhibitor shows promise in Phase I Study: TD-1473

Theravance Biopharma Reports Positive Results From Phase 1 Clinical Trial of a GI-Targeted Pan-Janus Kinase (JAK) Inhibitor TD-1473 showed a reduction in plasma exposure compared to?currently-approved JAK inhibitor. On June 9, 2016, Theravance Biopharma released positive results from a completed Phase I clinical trial of TD-1473, its oral GI-targeted pan-Janus kinase (JAK) inhibitor. TD-1473 is[…]